oxonic acid has been researched along with Digestive System Neoplasms in 2 studies
Oxonic Acid: Antagonist of urate oxidase.
Digestive System Neoplasms: Tumors or cancer of the DIGESTIVE SYSTEM.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Thus, the reduced efficacy of standard chemotherapy dosage in Chinese cancer patients may be explained by the lack of CYP2A6-mediated S-1 bioconversion to 5-FU." | 1.38 | Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy. ( Fang, WJ; Huang, MZ; Jin, DZ; Mao, CY; Mou, HB; Peng, L; Xu, N; Zhao, P; Zheng, YL, 2012) |
| " However, many patients are often forced to give up long-term S-1 treatment owing to high incidence rates of adverse effects." | 1.36 | [Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan]. ( Hazama, S; Nakazawa, S; Suga, T; Watanabe, S; Yagi, M; Yoshino, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yagi, M | 1 |
| Watanabe, S | 1 |
| Yoshino, S | 1 |
| Hazama, S | 1 |
| Suga, T | 1 |
| Nakazawa, S | 1 |
| Fang, WJ | 1 |
| Mou, HB | 1 |
| Jin, DZ | 1 |
| Zheng, YL | 1 |
| Zhao, P | 1 |
| Mao, CY | 1 |
| Peng, L | 1 |
| Huang, MZ | 1 |
| Xu, N | 1 |
2 other studies available for oxonic acid and Digestive System Neoplasms
| Article | Year |
|---|---|
[Provision for adverse effect of S-1 containing chemotherapy in patients with advanced digestive cancer--combination with superfine dispersed lentinan].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Colorectal Neoplasms; Digestive System Neoplas | 2010 |
Characteristic CYP2A6 genetic polymorphisms detected by TA cloning-based sequencing in Chinese digestive system cancer patients with S-1 based chemotherapy.
Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Aryl Hydrocarbon Hydroxylases; Base Sequen | 2012 |